Skip to main content
Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
100.27
-0.40 (-0.40%)
At close: Nov 13, 2026, 4:00 PM EST
99.48
-0.79 (-0.79%)
After-hours: Nov 13, 2026, 7:56 PM EST

Halozyme Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
485.42316.89444.09281.59202.13402.71
Depreciation & Amortization
128.5888.0581.3184.8649.643
Other Amortization
8.677.517.357.37.843.64
Loss (Gain) From Sale of Assets
2.72.621.530.610.13-
Asset Writedown & Restructuring Costs
333.59333.59----
Loss (Gain) From Sale of Investments
-1.49-3.47-10.93-6.322.832.26
Stock-Based Compensation
67.7151.5743.3936.6224.420.82
Other Operating Activities
-10.677.061.622.5839.09-136.72
Change in Accounts Receivable
-177.63-128.06-74.25-3.34-83.946.76
Change in Inventory
69.532.55-67.38-26.88-17.487.37
Change in Accounts Payable
26.926.2146.99-12.5524.541.17
Change in Other Net Operating Assets
-35.04-32.965.364.1-9.06-11.56
Operating Cash Flow
898.27651.56479.06388.57240.11299.44
Operating Cash Flow Growth
47.02%36.01%23.29%61.83%-19.81%439.98%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-12.39-6.97-10.7-15.29-4.81-1.46
Sale of Property, Plant & Equipment
----26.01-
Cash Acquisitions
-725.26-725.97---999.12-
Sale (Purchase) of Intangibles
-287.77-287.77----
Investment in Securities
239.04474.89-252.03-81.62490.92-404.83
Investing Cash Flow
-786.38-545.81-262.72-96.91-487.01-406.29

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
----370-
Long-Term Debt Issued
-1,470--702784.88
Total Debt Issued
2,9421,470--1,072784.88
Short-Term Debt Repaid
-----370-
Long-Term Debt Repaid
--1,013--13.48-77.45-369.06
Total Debt Repaid
-1,665-1,013--13.48-447.45-369.06
Net Debt Issued (Repaid)
1,277456.61--13.48624.55415.81
Issuance of Common Stock
31.8121.8331.147.8814.0512.54
Repurchase of Common Stock
-400-342.37-250-402.38-200-350.06
Other Financing Activities
-409.21-221.24---76.22-0.42
Financing Cash Flow
499.3-85.17-218.86-407.99362.3777.87

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
611.1820.57-2.52-116.33115.48-28.98

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
885.88644.59468.37373.28235.3297.98
Free Cash Flow Growth
47.06%37.62%25.47%58.64%-21.04%462.76%
Free Cash Flow Margin
49.15%46.15%46.13%45.01%35.64%67.22%
Free Cash Flow Per Share
7.245.203.622.781.672.03
Levered Free Cash Flow
427.85184.83402.48275.68146.42197.82
Unlevered Free Cash Flow
432.96188.65406.44280.1149.17198.88

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
11.4311.4310.5711.416.113.3
Cash Income Tax Paid
134.64134.6480.6231.7616.22-0.38
Change in Working Capital
-116.23-152.26-89.28-38.67-85.953.74
SEC Filings: 10-K · 10-Q